Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Eguchi

Showing results (81-90 of 239) with videos related to

Pageof 24
Sort By:
Journal of Hepatology|October 7, 2004
Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosisMie Inao, Satoshi Mochida, Atsushi Matsui, et al.
Hepato-Gastroenterology|August 12, 2010
Presence of esophageal varices is a risk factor for non-hemorrhagic death of hepatocellular carcinoma patients treated with radiofrequency ablationKeisuke Ario, Toshihiko Mizuta, Yuichiro Eguchi, et al.
Hepato-Gastroenterology|May 3, 2013
Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injectionSatoshi Oeda, Toshihiko Mizuta, Hiroshi Isoda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 22, 2019
Profiles of advanced hepatic fibrosis evaluated by FIB-4 index and shear wave elastography in health checkup examineesSakura Yamamura, Takumi Kawaguchi, Dan Nakano, et al.
International Journal of Molecular Sciences|August 14, 2020
Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic SteatohepatitisMotoyasu Kojima, Hirokazu Takahashi, Takuya Kuwashiro, et al.
International Cancer Conference Journal|June 1, 2019
A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinomaShingo Toyama, Yoshiyuki Shioyama, Hiroaki Suefuji, et al.
Journal of Gastroenterology|November 28, 2017
Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methodsMasato Yoneda, Kento Imajo, Hirokazu Takahashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2010
Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patientsHirokazu Takahashi, Toshihiko Mizuta, Seiji Kawazoe, et al.
International Journal of Molecular Medicine|May 23, 2018
Regulation of interferon signaling and HCV‑RNA replication by extracellular matrixTakuya Kuwashiro, Shinji Iwane, Xia Jinghe, et al.
Journal of Gastroenterology|March 4, 2015
Biphasic effect of alcohol intake on the development of fatty liver diseaseHirokazu Takahashi, Masafumi Ono, Hideyuki Hyogo, et al.
Pageof 24

Showing results (81-90 of 239) with videos related to

Sort By:
Pageof 24
Journal of Hepatology|October 7, 2004
Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosisMie Inao, Satoshi Mochida, Atsushi Matsui, et al.
Hepato-Gastroenterology|August 12, 2010
Presence of esophageal varices is a risk factor for non-hemorrhagic death of hepatocellular carcinoma patients treated with radiofrequency ablationKeisuke Ario, Toshihiko Mizuta, Yuichiro Eguchi, et al.
Hepato-Gastroenterology|May 3, 2013
Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injectionSatoshi Oeda, Toshihiko Mizuta, Hiroshi Isoda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 22, 2019
Profiles of advanced hepatic fibrosis evaluated by FIB-4 index and shear wave elastography in health checkup examineesSakura Yamamura, Takumi Kawaguchi, Dan Nakano, et al.
International Journal of Molecular Sciences|August 14, 2020
Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic SteatohepatitisMotoyasu Kojima, Hirokazu Takahashi, Takuya Kuwashiro, et al.
International Cancer Conference Journal|June 1, 2019
A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinomaShingo Toyama, Yoshiyuki Shioyama, Hiroaki Suefuji, et al.
Journal of Gastroenterology|November 28, 2017
Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methodsMasato Yoneda, Kento Imajo, Hirokazu Takahashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2010
Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patientsHirokazu Takahashi, Toshihiko Mizuta, Seiji Kawazoe, et al.
International Journal of Molecular Medicine|May 23, 2018
Regulation of interferon signaling and HCV‑RNA replication by extracellular matrixTakuya Kuwashiro, Shinji Iwane, Xia Jinghe, et al.
Journal of Gastroenterology|March 4, 2015
Biphasic effect of alcohol intake on the development of fatty liver diseaseHirokazu Takahashi, Masafumi Ono, Hideyuki Hyogo, et al.
Pageof 24